AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $110,000 | -91.4% | 17,927 | -86.0% | 0.01% | -76.0% |
Q2 2019 | $1,282,000 | +504.7% | 128,375 | +678.2% | 0.05% | +316.7% |
Q1 2019 | $212,000 | +16.5% | 16,497 | +37.5% | 0.01% | +33.3% |
Q4 2018 | $182,000 | -90.9% | 12,000 | -86.5% | 0.01% | -70.0% |
Q1 2017 | $1,997,000 | +662.2% | 88,600 | +728.0% | 0.03% | +233.3% |
Q3 2016 | $262,000 | -48.3% | 10,700 | -50.7% | 0.01% | -64.0% |
Q1 2016 | $507,000 | -38.0% | 21,700 | -19.9% | 0.02% | -50.0% |
Q4 2015 | $818,000 | -69.5% | 27,100 | -59.9% | 0.05% | -75.2% |
Q3 2015 | $2,685,000 | – | 67,600 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |